Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-Year outcome

Retina

Volumn 27, Issue 4, 2007, Pages 458-461

  Ruiz Moreno, Josi M ^a,b,d   Montero, Javier A ^b   Zarbin, Marco A ^c  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Vitreo Retinal Unit ^*  (Spain)

^c INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Intravitreal triamcinolone; Photodynamic therapy

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOPHTHALMITIS; FOLLOW UP; HUMAN; INTERVENTION STUDY; INTRAOCULAR PRESSURE; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; WILCOXON SIGNED RANKS TEST;

CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; EXUDATES AND TRANSUDATES; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 34247230252     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318030c77c     Document Type: Article

References (25)

1. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003;110:1517-1525.
2. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005;112:301-304.
3. Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age related macular degeneration. Br J Ophthalmol 2004;88:344-347.
4. Chan WN, Lai TY, Wong AL, et al. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularization in age related macular degeneration. A comparative study. Br J Ophthalmol 2006;90:337-341.
5. Krebs I, Binder S, Stolba U. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2005;6:1-5.
6. Nicolo M, Ghiglione D, Lai S, et al. Occult with no classic choroidal neovascularization secondary to age related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Retina 2006;26:58-64.
7. Augustin AJ, Schmidt-Erfurth U. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age related macular degeneration. Ophthalmology 2006;113:14-22.
8. Augustin AJ, Schmidt-Erfurth U. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age related macular degeneration. Am J Ophthalmol 2006;141:638-645.
9. Ruiz-Moreno JM, Montero J, Barile S, Zarbin M. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome. Retina 2006;26:602-612.
10. Ruiz-Moreno JM, Montero J, Barile S. Triamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhage. Eur J Ophthalmol 2006;16:426-434.
11. Chylack LT, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993;111:831-836.
12. Sharma S, Brown GC, Brown MM, et al. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2001;108:2051-2059.
13. Brown GC, Brown MM, Bampanella J, Bauchamp GR. The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration - a value-based reappraisal with 5-year data. Am J Ophthalmol 2005;140:679-687.
14. Meads C, Hyde C. Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review. Br J Ophthalmol 2004;88:212-217.
15. Reinke MH, Cankis C, Husain D, et al. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 1999;106:1915-1923.
16. Peyman GA, Kazi AA, Unal M, et al. Problems with and pitfalls of photodynamic therapy. Ophthalmology 2000;107:29-35.
17. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995;113:810-818.
18. Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001;119:399-404.
19. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of pre-retinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 1996;103:2099-2104.
20. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980;90:810-816.
21. Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1993;231:34-40.
22. Gillies MC, Simpson JM, Bilson FA, et al. Safety of an intravitreal injection of triamcinolone. Results from a randomized clinical trial. Arch Ophthalmol 2004;122:336-340.
23. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 2005;24:587-611.
24. Gillies MC, Kuzniarz M, Craig J, et al. Intravitreal triamcinolone- induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 2005;112:139-143.
25. Sears JE, Hoppe G. Triamcinolone acetonide destabilizes VEGF mRNA in Muller cells under continuous cobalt stimulation. Invest Ophthalmol Vis Sci 2005;46:4336-4341.